Mutual of Omaha Bank Wealth Management reduced its position in shares of MetLife, Inc. (NYSE:MET) by 7.5% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 5,945 shares of the financial services provider’s stock after selling 480 shares during the period. Mutual of Omaha Bank Wealth Management’s holdings in MetLife were worth $327,000 at the end of the most recent reporting period.

Other large investors have also made changes to their positions in the company. BlackRock Inc. boosted its stake in shares of MetLife by 3,323.3% in the first quarter. BlackRock Inc. now owns 68,475,870 shares of the financial services provider’s stock worth $3,616,895,000 after buying an additional 66,475,603 shares during the last quarter. Vanguard Group Inc. boosted its stake in shares of MetLife by 3.0% in the first quarter. Vanguard Group Inc. now owns 65,364,620 shares of the financial services provider’s stock worth $3,452,559,000 after buying an additional 1,885,246 shares during the last quarter. Renaissance Technologies LLC acquired a new stake in shares of MetLife during the first quarter worth about $82,954,000. APG Asset Management N.V. boosted its stake in shares of MetLife by 53.8% in the first quarter. APG Asset Management N.V. now owns 3,902,274 shares of the financial services provider’s stock worth $206,118,000 after buying an additional 1,365,018 shares during the last quarter. Finally, Canada Pension Plan Investment Board boosted its stake in shares of MetLife by 115.5% in the first quarter. Canada Pension Plan Investment Board now owns 2,367,139 shares of the financial services provider’s stock worth $125,032,000 after buying an additional 1,268,600 shares during the last quarter. 74.83% of the stock is owned by institutional investors.

MetLife, Inc. (NYSE:MET) traded up 1.09% on Tuesday, hitting $49.06. The stock had a trading volume of 3,033,370 shares. MetLife, Inc. has a 1-year low of $38.87 and a 1-year high of $58.09. The stock has a market capitalization of $53.34 billion, a price-to-earnings ratio of 551.24 and a beta of 1.46. The company has a 50-day moving average price of $54.59 and a 200-day moving average price of $53.07.

MetLife (NYSE:MET) last announced its quarterly earnings data on Wednesday, August 2nd. The financial services provider reported $1.30 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.28 by $0.02. The company had revenue of $17.39 billion for the quarter, compared to analysts’ expectations of $17.11 billion. MetLife had a return on equity of 8.51% and a net margin of 0.30%. MetLife’s revenue for the quarter was up 2.5% compared to the same quarter last year. During the same period last year, the firm posted $0.83 EPS. Equities analysts predict that MetLife, Inc. will post $4.97 earnings per share for the current year.

The company also recently disclosed a quarterly dividend, which will be paid on Wednesday, September 13th. Investors of record on Monday, August 7th will be issued a dividend of $0.40 per share. The ex-dividend date of this dividend is Thursday, August 3rd. This represents a $1.60 dividend on an annualized basis and a dividend yield of 3.30%. MetLife’s dividend payout ratio is 1,777.98%.

ILLEGAL ACTIVITY WARNING: “MetLife, Inc. (NYSE:MET) Shares Sold by Mutual of Omaha Bank Wealth Management” was first posted by Daily Political and is the sole property of of Daily Political. If you are viewing this news story on another publication, it was illegally stolen and reposted in violation of US and international copyright and trademark law. The correct version of this news story can be viewed at https://www.dailypolitical.com/2017/08/08/metlife-inc-nysemet-shares-sold-by-mutual-of-omaha-bank-wealth-management.html.

MET has been the subject of a number of recent research reports. TheStreet cut shares of MetLife from a “b-” rating to a “c” rating in a research report on Tuesday, May 16th. ValuEngine raised shares of MetLife from a “buy” rating to a “strong-buy” rating in a research report on Tuesday, June 27th. Citigroup Inc. set a $51.00 price objective on shares of MetLife and gave the stock a “sell” rating in a research report on Friday, July 7th. Zacks Investment Research raised shares of MetLife from a “hold” rating to a “buy” rating and set a $59.00 price objective for the company in a research report on Tuesday, April 11th. Finally, BidaskClub raised shares of MetLife from a “strong sell” rating to a “sell” rating in a research report on Saturday, June 10th. Two investment analysts have rated the stock with a sell rating, six have issued a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. MetLife presently has a consensus rating of “Hold” and a consensus target price of $59.02.

MetLife Company Profile

MetLife, Inc is a provider of life insurance, annuities, employee benefits and asset management. The Company’s segments include U.S.; Asia; Latin America; Europe, the Middle East and Africa (EMEA); MetLife Holdings; Brighthouse Financial, and Corporate & Other. Its U.S. segment is organized into Group Benefits, Retirement and Income Solutions and Property & Casualty businesses.

Want to see what other hedge funds are holding MET? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for MetLife, Inc. (NYSE:MET).

Institutional Ownership by Quarter for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife Inc. and related companies with MarketBeat.com's FREE daily email newsletter.